MAPSAP 40MG INJ

MAPSAP 40MG INJ contains Esomeprazole, a proton pump inhibitor used to reduce stomach acid production. It is indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease, and acid-related conditions. This injectable formulation provides rapid onset of action and is suitable for patients who cannot take oral medications. Administered intravenously or intramuscularly as directed by a healthcare professional. Each injection delivers 40mg of Esomeprazole for effective acid suppression and symptom relief.